skip to Main Content

CONNECTING LEADERS

In Science And Business

2023 EVENTS

July 2023
No event found!

WHO WE ARE

The Life Sciences Collaborative is a select group of industry veterans and executives from the pharmaceutical, biotechnology, and medical device sectors and industry service providers who share a common vision of increasing the success.

LSC activities are built around small, informal, monthly breakfast educational and networking meetings. These sessions focus on topics around innovation and investment, including industry trends, practical issues related to growing and managing innovative businesses, and best practices.

OUR PARTNERS

MISSON STATEMENT

The mission of the Life Sciences Collaborative is to promote connectivity among leaders in emerging life sciences businesses through networking, education, training, and mentorship with the goal of advancing professionals.

LSC is a volunteer organization. It is neither sponsorship nor membership dues driven. If you are interested in participating in LSC’s monthly breakfast meetings, please contact us.

MISSON STATEMENT

The mission of the Life Sciences Collaborative is to promote connectivity among leaders in emerging life sciences businesses through networking, education, training, and mentorship with the goal of advancing professional.

LSC EVENTS

The meetings also include presentations by emerging companies, providing them with
opportunities to get expert feedback on their technologies and to expand their networks.

No event found!

LSC MEMBERS

CEOs, Directors, Private Equity and Venture Partners, Angel Investors

Members may have successful track record leading public or private companies.

David Barone

Position: Boston Medtech Advisors
Categories: 2. PLANNING COMMITTEE, 3. MEMBERS, Boston, MA

David Barone

Boston Medtech Advisors

David Kerr

Position: Vice President Business Development; Syneos Health Commercial Solutions
Categories: 2. EVENT COMMITTEE, King of Prussia, PA

David Kerr

Vice President Business Development; Syneos Health Commercial Solutions

Dawn Flitcraft

Position: Chief M&A Intergration Officer; WCG Clinical
Categories: 3. EXECUTIVE OFFICERS, King of Prussia, PA

Dawn Flitcraft

Chief M&A Intergration Officer; WCG Clinical

Eileen McCullough

Categories: 3. MEMBERS, Boston, MA

Eileen McCullough

Ellen Derrico

Position: Marketing Consultant
Categories: 3. EXECUTIVE OFFICERS, King of Prussia, PA

Ellen Derrico

Marketing Consultant

Eric Silver, Ph.D

Position: Imagine Scientific, Inc.
Categories: 3. EXECUTIVE OFFICERS, 3. MEMBERS, Boston, MA

Eric Silver, Ph.D

Imagine Scientific, Inc.

Erika Geimonen

Position: Vice President, Business Development; Amring Pharmaceuticals
Categories: 2. EVENT COMMITTEE, King of Prussia, PA

Erika Geimonen

Vice President, Business Development; Amring Pharmaceuticals

Eshwar Inapuri

Position: Chief Executive Officer; Innamed
Categories: 3. EXECUTIVE OFFICERS, King of Prussia, PA

Eshwar Inapuri

Chief Executive Officer; Innamed

Frank Leu

Position: Auditor; RSM
Categories: 2. EVENT COMMITTEE, King of Prussia, PA

Frank Leu

Auditor; RSM

Fred Meyer, Ph.D

Position: CicloMed
Categories: 1. CO-CHAIR, 2. PLANNING COMMITTEE, 3. EXECUTIVE OFFICERS, 3. MEMBERS, Boston, MA

Fred Meyer, Ph.D

CicloMed

Greg Ambra, MS, MBA

Position: Independent Consultant l Clinical Development Advisor
Categories: 2. PLANNING COMMITTEE, LSC – New Jersey

Greg Ambra, MS, MBA

Independent Consultant l Clinical Development Advisor

Greg Baker

Position: Boston Children's Hospital
Categories: 3. EXECUTIVE OFFICERS, 3. MEMBERS, Boston, MA

Greg Baker

Boston Children's Hospital

Greg House

Position: Principle; Real World Outcomes LLC
Categories: 2. EVENT COMMITTEE, King of Prussia, PA

Greg House

Principle; Real World Outcomes LLC

Glenn Whaley

Position: Chief Financial Officer at Immunic Therapeutics (Nasdaq:IMUX)
Categories: 3. MEMBERS, LSC – New Jersey

Glenn Whaley

Chief Financial Officer at Immunic Therapeutics (Nasdaq:IMUX)

Harry Atkins

Position: Senior Director, Alliance Management; Incyte Corporation
Categories: 2. EVENT COMMITTEE, King of Prussia, PA

Harry Atkins

Senior Director, Alliance Management; Incyte Corporation

Ihor Terleckyj, Ph.D.

Position: Chief Executive Officer; CuRAGE Therapeutics
Categories: LSC – New Jersey

Ihor Terleckyj, Ph.D.

Chief Executive Officer; CuRAGE Therapeutics

Ira Spector

Position: CEO at SFA Therapeutics, Inc
Categories: 3. MEMBERS, LSC – New Jersey

Ira Spector

CEO at SFA Therapeutics, Inc

Jack Foster

Position: Vice President of Finance; InClinica, Inc.
Categories: 2. EVENT COMMITTEE, King of Prussia, PA

Jack Foster

Vice President of Finance; InClinica, Inc.

JeanMarie Markham

Position: Consultant / Independent Board Director
Categories: 3. MEMBERS, LSC – New Jersey

JeanMarie Markham

Consultant / Independent Board Director

Jeremy Sohn

Position: p74 Ventures
Categories: 3. EXECUTIVE OFFICERS, 3. MEMBERS, Boston, MA

Jeremy Sohn

p74 Ventures

WHAT OUR MEMBERS SAY

“The LSC has given me instant access to a number of subject matter experts as well new connections to colleagues up and down the East Coast!”

Mike Webb
President and CEO, CXL Ophthalmics

“I learn something new and valuable at every LSC event. I’ve been able to make new connections & friends in every aspect of the ecosystem.” 

Mark Moody PhD
COO, Activate Therapeutics

“I learn something new and valuable at every LSC event. I’ve been able to make new connections & friends in every aspect of the ecosystem.” 

Mark Moody PhD
COO, Activate Therapeutics